News

Back

Exothera announces the appointment of Darren Leva as Chief Business Officer

February 1st 2023

BSCB Dev

Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO) specialized in gene therapy, vaccines, and oncolytic viruses, today announced that it has appointed Darren Leva as Chief Business Officer. Darren’s extensive commercial experience in biotherapeutics CDMOs will further extend Exothera’s business and commercial capability across existing and brand-new markets.

Read Pdf